Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes

Monia E. Werlang, William C. Palmer, Evelyn A. Boyd, David J. Cangemi, Denise Harnois, Cemal B. Taner, Fernando F. Stancampiano

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim: Patent foramen ovale (PFO) is a common atrial septal defect that is largely asymptomatic and often undiagnosed. The impact of a PFO in patients undergoing liver transplantation (LT) is unknown. Objective: Assess the impact of PFO and physiologic intrapulmonary shunt (IPS) on the perioperative outcomes of patients who underwent LT. Methods: We performed a retrospective, intention-to-treat analysis of patients with PFO and controls without PFO who underwent LT at Mayo Clinic in Florida between 2008 and 2013. Patients with physiologic IPS were also analyzed. The cohorts were compared for baseline characteristics, length of stay in the intensive care unit (ICU), postoperative oxygen requirements, 30-d cerebrovascular accidents, and mortality. Results: Of the 935 patients who underwent LT, 10.4% had proven PFO by pre-LT echocardiogram. Control patients (n = 101) were statistically older than PFO and IPS (n = 56) patients, but similar in sex, BMI, Model for End-stage Liver Disease score, American Society of Anesthesiologist score, and left ventricular ejection fraction. PFO and IPS patients had similar length of stay in the ICU, mechanical ventilation times, post-LT oxygen requirements, and 30-d mortality compared to controls. Subgroup analysis showed similar outcomes for large PFO and IPS patients to controls. Conclusions: The presence of PFO did not have a negative impact on perioperative LT outcomes.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalClinical Transplantation
Volume30
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Patent Foramen Ovale
Liver Transplantation
Liver
Intensive Care Units
Length of Stay
Transplant Recipients
Oxygen
End Stage Liver Disease
Intention to Treat Analysis
Atrial Heart Septal Defects
Mortality
Artificial Respiration
Stroke Volume
Stroke

Keywords

  • Intrapulmonary shunt
  • Liver transplantation
  • Mortality
  • Patent foramen ovale
  • Preoperative evaluation

ASJC Scopus subject areas

  • Transplantation

Cite this

Werlang, M. E., Palmer, W. C., Boyd, E. A., Cangemi, D. J., Harnois, D., Taner, C. B., & Stancampiano, F. F. (2016). Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes. Clinical Transplantation, 30(1), 26-32. https://doi.org/10.1111/ctr.12643

Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes. / Werlang, Monia E.; Palmer, William C.; Boyd, Evelyn A.; Cangemi, David J.; Harnois, Denise; Taner, Cemal B.; Stancampiano, Fernando F.

In: Clinical Transplantation, Vol. 30, No. 1, 01.01.2016, p. 26-32.

Research output: Contribution to journalArticle

Werlang, ME, Palmer, WC, Boyd, EA, Cangemi, DJ, Harnois, D, Taner, CB & Stancampiano, FF 2016, 'Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes', Clinical Transplantation, vol. 30, no. 1, pp. 26-32. https://doi.org/10.1111/ctr.12643
Werlang, Monia E. ; Palmer, William C. ; Boyd, Evelyn A. ; Cangemi, David J. ; Harnois, Denise ; Taner, Cemal B. ; Stancampiano, Fernando F. / Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes. In: Clinical Transplantation. 2016 ; Vol. 30, No. 1. pp. 26-32.
@article{3931489926a643d1a6d8ec4cfbcb4ef0,
title = "Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes",
abstract = "Aim: Patent foramen ovale (PFO) is a common atrial septal defect that is largely asymptomatic and often undiagnosed. The impact of a PFO in patients undergoing liver transplantation (LT) is unknown. Objective: Assess the impact of PFO and physiologic intrapulmonary shunt (IPS) on the perioperative outcomes of patients who underwent LT. Methods: We performed a retrospective, intention-to-treat analysis of patients with PFO and controls without PFO who underwent LT at Mayo Clinic in Florida between 2008 and 2013. Patients with physiologic IPS were also analyzed. The cohorts were compared for baseline characteristics, length of stay in the intensive care unit (ICU), postoperative oxygen requirements, 30-d cerebrovascular accidents, and mortality. Results: Of the 935 patients who underwent LT, 10.4{\%} had proven PFO by pre-LT echocardiogram. Control patients (n = 101) were statistically older than PFO and IPS (n = 56) patients, but similar in sex, BMI, Model for End-stage Liver Disease score, American Society of Anesthesiologist score, and left ventricular ejection fraction. PFO and IPS patients had similar length of stay in the ICU, mechanical ventilation times, post-LT oxygen requirements, and 30-d mortality compared to controls. Subgroup analysis showed similar outcomes for large PFO and IPS patients to controls. Conclusions: The presence of PFO did not have a negative impact on perioperative LT outcomes.",
keywords = "Intrapulmonary shunt, Liver transplantation, Mortality, Patent foramen ovale, Preoperative evaluation",
author = "Werlang, {Monia E.} and Palmer, {William C.} and Boyd, {Evelyn A.} and Cangemi, {David J.} and Denise Harnois and Taner, {Cemal B.} and Stancampiano, {Fernando F.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1111/ctr.12643",
language = "English (US)",
volume = "30",
pages = "26--32",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Patent foramen ovale in liver transplant recipients does not negatively impact short-term outcomes

AU - Werlang, Monia E.

AU - Palmer, William C.

AU - Boyd, Evelyn A.

AU - Cangemi, David J.

AU - Harnois, Denise

AU - Taner, Cemal B.

AU - Stancampiano, Fernando F.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Aim: Patent foramen ovale (PFO) is a common atrial septal defect that is largely asymptomatic and often undiagnosed. The impact of a PFO in patients undergoing liver transplantation (LT) is unknown. Objective: Assess the impact of PFO and physiologic intrapulmonary shunt (IPS) on the perioperative outcomes of patients who underwent LT. Methods: We performed a retrospective, intention-to-treat analysis of patients with PFO and controls without PFO who underwent LT at Mayo Clinic in Florida between 2008 and 2013. Patients with physiologic IPS were also analyzed. The cohorts were compared for baseline characteristics, length of stay in the intensive care unit (ICU), postoperative oxygen requirements, 30-d cerebrovascular accidents, and mortality. Results: Of the 935 patients who underwent LT, 10.4% had proven PFO by pre-LT echocardiogram. Control patients (n = 101) were statistically older than PFO and IPS (n = 56) patients, but similar in sex, BMI, Model for End-stage Liver Disease score, American Society of Anesthesiologist score, and left ventricular ejection fraction. PFO and IPS patients had similar length of stay in the ICU, mechanical ventilation times, post-LT oxygen requirements, and 30-d mortality compared to controls. Subgroup analysis showed similar outcomes for large PFO and IPS patients to controls. Conclusions: The presence of PFO did not have a negative impact on perioperative LT outcomes.

AB - Aim: Patent foramen ovale (PFO) is a common atrial septal defect that is largely asymptomatic and often undiagnosed. The impact of a PFO in patients undergoing liver transplantation (LT) is unknown. Objective: Assess the impact of PFO and physiologic intrapulmonary shunt (IPS) on the perioperative outcomes of patients who underwent LT. Methods: We performed a retrospective, intention-to-treat analysis of patients with PFO and controls without PFO who underwent LT at Mayo Clinic in Florida between 2008 and 2013. Patients with physiologic IPS were also analyzed. The cohorts were compared for baseline characteristics, length of stay in the intensive care unit (ICU), postoperative oxygen requirements, 30-d cerebrovascular accidents, and mortality. Results: Of the 935 patients who underwent LT, 10.4% had proven PFO by pre-LT echocardiogram. Control patients (n = 101) were statistically older than PFO and IPS (n = 56) patients, but similar in sex, BMI, Model for End-stage Liver Disease score, American Society of Anesthesiologist score, and left ventricular ejection fraction. PFO and IPS patients had similar length of stay in the ICU, mechanical ventilation times, post-LT oxygen requirements, and 30-d mortality compared to controls. Subgroup analysis showed similar outcomes for large PFO and IPS patients to controls. Conclusions: The presence of PFO did not have a negative impact on perioperative LT outcomes.

KW - Intrapulmonary shunt

KW - Liver transplantation

KW - Mortality

KW - Patent foramen ovale

KW - Preoperative evaluation

UR - http://www.scopus.com/inward/record.url?scp=84953835217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953835217&partnerID=8YFLogxK

U2 - 10.1111/ctr.12643

DO - 10.1111/ctr.12643

M3 - Article

C2 - 26448343

AN - SCOPUS:84953835217

VL - 30

SP - 26

EP - 32

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 1

ER -